Radioimmunoscintigraphy using monoclonal antibodies to CEA, CA 19-9 and CA 125. 1988

R P Baum, and M Lorenz, and C Hottenrott, and M Albrecht, and R Senekowitsch, and J Happ, and A Hertel, and J Spitz, and G Hör
Department of Radiology, University of Frankfurt/Main, Fed. Rep. of Germany.

131I labelled F (ab')2 fragments of monoclonal antibodies against CA 19-9 and CEA ("radioimmunococktail" IMACIS 1) were used in a prospective study (n = 60 patients) and in a retrospective study (n = 32 patients) for the detection of colorectal carcinomas (n = 67) and other gastrointestinal CEA/CA 19-9-producing tumors (n = 32). Sensitivity was 82% and specificity 90%. Immunoscintigraphy proved useful and complementary to CT scan and sonography, especially in the diagnosis of pelvic recurrences and intra-abdominal metastases. In addition, monoclonal antibody OC 125 (IMACIS 2) was used for the detection of ovarian carcinomas (n = 10) and other CA 125 producing tumors. Immunoscintigraphy was positive in all patients (n = 18) suggesting that this radioimmunological approach could be of use in the staging, therapeutic control and earlier diagnosis of recurrent epithelial ovarian carcinoma.

UI MeSH Term Description Entries
D007140 Immunoglobulin Fab Fragments Univalent antigen-binding fragments composed of one entire IMMUNOGLOBULIN LIGHT CHAIN and the amino terminal end of one of the IMMUNOGLOBULIN HEAVY CHAINS from the hinge region, linked to each other by disulfide bonds. Fab contains the IMMUNOGLOBULIN VARIABLE REGIONS, which are part of the antigen-binding site, and the first IMMUNOGLOBULIN CONSTANT REGIONS. This fragment can be obtained by digestion of immunoglobulins with the proteolytic enzyme PAPAIN. Fab Fragment,Fab Fragments,Ig Fab Fragments,Immunoglobulins, Fab Fragment,Fab Immunoglobulin Fragments,Immunoglobulin Fab Fragment,Immunoglobulins, Fab,Fab Fragment Immunoglobulins,Fab Fragment, Immunoglobulin,Fab Fragments, Immunoglobulin,Fragment Immunoglobulins, Fab,Fragment, Fab,Immunoglobulin Fragments, Fab
D007457 Iodine Radioisotopes Unstable isotopes of iodine that decay or disintegrate emitting radiation. I atoms with atomic weights 117-139, except I 127, are radioactive iodine isotopes. Radioisotopes, Iodine
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010051 Ovarian Neoplasms Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS. Cancer of Ovary,Ovarian Cancer,Cancer of the Ovary,Neoplasms, Ovarian,Ovary Cancer,Ovary Neoplasms,Cancer, Ovarian,Cancer, Ovary,Cancers, Ovarian,Cancers, Ovary,Neoplasm, Ovarian,Neoplasm, Ovary,Neoplasms, Ovary,Ovarian Cancers,Ovarian Neoplasm,Ovary Cancers,Ovary Neoplasm
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D011877 Radionuclide Imaging The production of an image obtained by cameras that detect the radioactive emissions of an injected radionuclide as it has distributed differentially throughout tissues in the body. The image obtained from a moving detector is called a scan, while the image obtained from a stationary camera device is called a scintiphotograph. Gamma Camera Imaging,Radioisotope Scanning,Scanning, Radioisotope,Scintigraphy,Scintiphotography,Imaging, Gamma Camera,Imaging, Radionuclide
D002272 Carcinoembryonic Antigen A glycoprotein that is secreted into the luminal surface of the epithelia in the gastrointestinal tract. It is found in the feces and pancreaticobiliary secretions and is used to monitor the response to colon cancer treatment. Antigens, CD66e,CD66e Antigen,Antigen, CD66e,Antigen, Carcinoembryonic,CD66e Antigens
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

R P Baum, and M Lorenz, and C Hottenrott, and M Albrecht, and R Senekowitsch, and J Happ, and A Hertel, and J Spitz, and G Hör
February 1994, Annals of nuclear medicine,
R P Baum, and M Lorenz, and C Hottenrott, and M Albrecht, and R Senekowitsch, and J Happ, and A Hertel, and J Spitz, and G Hör
June 1989, Gan no rinsho. Japan journal of cancer clinics,
R P Baum, and M Lorenz, and C Hottenrott, and M Albrecht, and R Senekowitsch, and J Happ, and A Hertel, and J Spitz, and G Hör
December 1985, Nuklearmedizin. Nuclear medicine,
R P Baum, and M Lorenz, and C Hottenrott, and M Albrecht, and R Senekowitsch, and J Happ, and A Hertel, and J Spitz, and G Hör
February 1989, Gaoxiong yi xue ke xue za zhi = The Kaohsiung journal of medical sciences,
R P Baum, and M Lorenz, and C Hottenrott, and M Albrecht, and R Senekowitsch, and J Happ, and A Hertel, and J Spitz, and G Hör
January 2013, Archives of gynecology and obstetrics,
R P Baum, and M Lorenz, and C Hottenrott, and M Albrecht, and R Senekowitsch, and J Happ, and A Hertel, and J Spitz, and G Hör
August 1991, Geburtshilfe und Frauenheilkunde,
R P Baum, and M Lorenz, and C Hottenrott, and M Albrecht, and R Senekowitsch, and J Happ, and A Hertel, and J Spitz, and G Hör
May 1988, Geburtshilfe und Frauenheilkunde,
R P Baum, and M Lorenz, and C Hottenrott, and M Albrecht, and R Senekowitsch, and J Happ, and A Hertel, and J Spitz, and G Hör
December 1984, Nihon Gan Chiryo Gakkai shi,
R P Baum, and M Lorenz, and C Hottenrott, and M Albrecht, and R Senekowitsch, and J Happ, and A Hertel, and J Spitz, and G Hör
September 2023, Sensors (Basel, Switzerland),
R P Baum, and M Lorenz, and C Hottenrott, and M Albrecht, and R Senekowitsch, and J Happ, and A Hertel, and J Spitz, and G Hör
January 1986, Journal of cancer research and clinical oncology,
Copied contents to your clipboard!